$OXBR
Oxbridge Re Holdings Ltd

2014 Q2 Form 10-Q Financial Statement

#000119312514310105 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $899.0K $212.0K
YoY Change 324.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $230.0K $50.00K
YoY Change 360.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $130.0K $14.00K
YoY Change 828.57%
% of Gross Profit
Operating Expenses $358.0K $212.0K
YoY Change 68.87%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $540.0K $0.00
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $541.0K $0.00
YoY Change
Net Earnings / Revenue 60.18% 0.0%
Basic Earnings Per Share $0.09 $0.00
Diluted Earnings Per Share $0.09 $0.00
COMMON SHARES
Basic Shares Outstanding 6.000M shares 0.000 shares
Diluted Shares Outstanding 6.000M shares 0.000 shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $27.96M $6.557M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $49.00K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.560M
YoY Change
Other Assets $8.880M $0.00
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $50.82M $11.60M
YoY Change 338.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.00K $270.0K
YoY Change -74.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $70.00K $270.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $15.75M $4.940M
YoY Change 218.81%
SHAREHOLDERS EQUITY
Retained Earnings $1.520M
YoY Change
Common Stock $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.07M $6.660M
YoY Change
Total Liabilities & Shareholders Equity $50.82M $11.60M
YoY Change 338.06%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $541.0K $0.00
YoY Change
Depreciation, Depletion And Amortization $130.0K $14.00K
YoY Change 828.57%
Cash From Operating Activities $680.0K -$100.0K
YoY Change -780.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.250M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.00K 6.660M
YoY Change -99.25%
NET CHANGE
Cash From Operating Activities 680.0K -100.0K
Cash From Investing Activities -1.250M
Cash From Financing Activities 50.00K 6.660M
Net Change In Cash -520.0K 6.560M
YoY Change -107.93%
FREE CASH FLOW
Cash From Operating Activities $680.0K -$100.0K
Capital Expenditures $0.00
Free Cash Flow $680.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
6.00
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6000000 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6557000
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6000000 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8230700 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6000000 shares
CY2014Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1.00 pure
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8230700 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
7.50
CY2014Q2 us-gaap Reinsurance Payable
ReinsurancePayable
3027000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33540000
CY2014Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
35066000
CY2014Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
69000
CY2014Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
7300000
CY2014Q2 us-gaap Unearned Premiums
UnearnedPremiums
12653000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1520000
CY2014Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
0
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50815000
CY2014Q2 us-gaap Liabilities
Liabilities
15749000
CY2014Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
500
CY2014Q2 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
0
CY2014Q2 us-gaap Investments
Investments
0
CY2014Q2 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
13483000
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8876000
CY2014Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2014Q2 us-gaap Reinsurance Receivables Paid Losses Recoverable
ReinsuranceReceivablesPaidLossesRecoverable
0
CY2014Q2 us-gaap Assets
Assets
50815000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27956000
CY2014Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
36832000
CY2014Q2 us-gaap Deferred Policy Acquisition Costs Net
DeferredPolicyAcquisitionCostsNet
291000
CY2014Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
160000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49000
CY2014Q2 oxbr Uncertain Tax Position
UncertainTaxPosition
0
CY2014Q2 oxbr Loss Experience Refund Payable
LossExperienceRefundPayable
8200000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1115350 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1115350 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Reinsurance Payable
ReinsurancePayable
1367000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6595000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
7449000
CY2013Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
511000
CY2013Q4 us-gaap Unearned Premiums
UnearnedPremiums
2036000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
853000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11363000
CY2013Q4 us-gaap Liabilities
Liabilities
3914000
CY2013Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
0
CY2013Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
0
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10118000
CY2013Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
417000
CY2013Q4 us-gaap Assets
Assets
11363000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
695000
CY2013Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
10813000
CY2013Q4 us-gaap Deferred Policy Acquisition Costs Net
DeferredPolicyAcquisitionCostsNet
69000
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
64000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
0 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-98000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
0 shares
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
us-gaap Revenues
Revenues
212000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
4721000
us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
4886000
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-195000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
152000
us-gaap Interest Paid
InterestPaid
0
us-gaap Premiums Earned Net
PremiumsEarnedNet
212000
us-gaap Net Income Loss
NetIncomeLoss
0
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6655000
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
4479000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6557000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
270000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000
us-gaap Pre Opening Costs
PreOpeningCosts
145000
us-gaap Depreciation
Depreciation
0
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
14000
us-gaap Operating Expenses
OperatingExpenses
212000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
3174000
oxbr Amortization Of Broker Placement Fees
AmortizationOfBrokerPlacementFees
9721
oxbr Decrease Increase In Offering Costs
DecreaseIncreaseInOfferingCosts
162000
oxbr Proceeds From Contributed Warrant
ProceedsFromContributedWarrant
3480000
dei Entity Registrant Name
EntityRegistrantName
OXBRIDGE RE HOLDINGS Ltd
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001584831
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.48 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3706104 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 8%"> <b><u>Allowance for uncollectible receivables:</u></b> Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At June&#xA0;30, 2014, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.</p> </div>
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
633000
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0169 pure
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3706104 shares
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.24
us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
For income tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority.
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.08 pure
us-gaap Revenues
Revenues
1548000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
96000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
268000
us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
13483000
us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
13825000
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-1660000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5080000
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
222000
us-gaap Interest Paid
InterestPaid
0
us-gaap Premiums Earned Net
PremiumsEarnedNet
1548000
us-gaap Net Income Loss
NetIncomeLoss
935000
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
832000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-1242000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21870000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
54000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
440000
us-gaap Dividends Common Stock
DividendsCommonStock
268000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
26682000
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
10617000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
27261000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-442000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000
us-gaap Pre Opening Costs
PreOpeningCosts
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
29300000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Depreciation
Depreciation
5000
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
173000
us-gaap Operating Expenses
OperatingExpenses
613000
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
21865000
oxbr Dividends Declared
DividendsDeclared
267684
oxbr Amortization Of Broker Placement Fees
AmortizationOfBrokerPlacementFees
48605
oxbr Decrease Increase In Offering Costs
DecreaseIncreaseInOfferingCosts
-417000
oxbr Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
0 shares
oxbr Net Proceeds After Deducting Underwriters Commission
NetProceedsAfterDeductingUnderwritersCommission
26900000
oxbr Proceeds From Contributed Warrant
ProceedsFromContributedWarrant
5080000
oxbr Collateral Transferred Under Agreement
CollateralTransferredUnderAgreement
17500000
CY2014Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
7.50
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4884650 shares
CY2014Q1 oxbr Closing Price Per Share Common Stock
ClosingPricePerShareCommonStock
9.38
CY2014Q1 oxbr Number Of Warrant Unit Sold
NumberOfWarrantUnitSold
1 shares
CY2014Q1 oxbr Number Of Ordinary Shares Offered For Sale
NumberOfOrdinarySharesOfferedForSale
1 shares
CY2014Q1 oxbr Number Of Trading Period
NumberOfTradingPeriod
P10D
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2013Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
7.50
CY2013Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1115350 shares
CY2013Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6700000
CY2013Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3479892
CY2013Q2 oxbr Class Of Warrant Or Rights Date Up To Which Warrants Or Rights Exercisable
ClassOfWarrantOrRightsDateUpToWhichWarrantsOrRightsExercisable
2018-05-31
CY2013 us-gaap Payments For Brokerage Fees
PaymentsForBrokerageFees
116651
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
0 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
0 shares
CY2013Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
CY2013Q2 us-gaap Revenues
Revenues
212000
CY2013Q2 us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
CY2013Q2 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
4886000
CY2013Q2 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-195000
CY2013Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
212000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
0
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53000
CY2013Q2 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
4479000
CY2013Q2 us-gaap Pre Opening Costs
PreOpeningCosts
145000
CY2013Q2 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
14000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
212000
CY2013Q2 oxbr Amortization Of Broker Placement Fees
AmortizationOfBrokerPlacementFees
9721
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6000000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6000000 shares
CY2014Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
CY2014Q2 us-gaap Revenues
Revenues
899000
CY2014Q2 us-gaap Increase Decrease In Loss And Loss Adjustment Expense Reserve
IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve
0
CY2014Q2 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
13767000
CY2014Q2 us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-1075000
CY2014Q2 us-gaap Premiums Earned Net
PremiumsEarnedNet
899000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
541000
CY2014Q2 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
484000
CY2014Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
228000
CY2014Q2 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
11793000
CY2014Q2 us-gaap Pre Opening Costs
PreOpeningCosts
0
CY2014Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2014Q2 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
130000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
358000
CY2014Q2 oxbr Amortization Of Broker Placement Fees
AmortizationOfBrokerPlacementFees
19442
CY2014Q2 oxbr Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
0 shares

Files In Submission

Name View Source Status
0001193125-14-310105-index-headers.html Edgar Link pending
0001193125-14-310105-index.html Edgar Link pending
0001193125-14-310105.txt Edgar Link pending
0001193125-14-310105-xbrl.zip Edgar Link pending
d743701d10q.htm Edgar Link pending
d743701dex311.htm Edgar Link pending
d743701dex312.htm Edgar Link pending
d743701dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
oxbr-20140630.xml Edgar Link completed
oxbr-20140630.xsd Edgar Link pending
oxbr-20140630_cal.xml Edgar Link unprocessable
oxbr-20140630_def.xml Edgar Link unprocessable
oxbr-20140630_lab.xml Edgar Link unprocessable
oxbr-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending